<DOC>
	<DOCNO>NCT01492218</DOCNO>
	<brief_summary>This study conduct Asia . The aim study assess patient satisfaction switch biphasic human insulin 30 treatment use NovoLet® insulin device treatment diabetes mellitus normal clinical practice setting .</brief_summary>
	<brief_title>Observational Study With Mixtard® 30 NovoLet® Assess Patient Satisfaction</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin , pork ; isophane insulin , pork drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diabetes mellitus ( type 1 type 2 ) Patient presently use Mixtard® 30 NovoLet®</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>